
Opinion|Videos|October 21, 2024
Severity and Impact of Alopecia Areata
Key Takeaways
- Alopecia severity is assessed using tools like the AA scale and ASAMI Study guidelines to quantify hair loss extent.
- These tools help evaluate the psychological and social impact of alopecia on patients, aiding in personalized treatment.
Panelists discuss how they determine disease severity in patients with alopecia areata, highlighting the tools used in clinical practice, such as the AA scale 2022 and the ASAMI study 2024.
Advertisement
Episodes in this series

Video content above is prompted by the following:
How do you determine disease severity in patients with alopecia?
What tools do you use in the clinic to assess disease severity (AA scale 2022,
Advertisement
Related to this article

The FDA updated the risankizumab label to make pretreatment TB evaluation a matter of clinical judgment across all indications, including psoriasis.

Phase 2 and 3 data show difamilast 1% ointment improved severity and itch within 1 week in adults and children with mild to moderate atopic dermatitis.

Final VALUE data show fewer drug changes with risankizumab vs other biologics over 37 months in patients with psoriasis and comorbid psoriatic arthritis.

Stay updated with the latest healthcare breakthroughs, including new TRANSCEND-T2D-2 data and FDA actions.

The plasmid DNA immunotherapy Voceryq gained FDA accelerated approval after 27% of RRP-001 patients needed no surgery for 12 months.

IgAN late-breakers led the meeting, alongside new data on aspirin, dialysis access, donor pregnancy, potassium, and depression.

Experts discuss remibrutinib, the first FDA-approved therapy for symptomatic dermographism: RemIND data, bleeding counseling, and where it fits in practice
Advertisement
Advertisement
Trending on HCPLive
1
Cardiac Health Indicators Improve Following CCM Implantation in Heart Failure
2
Sarcoidosis Care Starts With Inflammation vs Fibrosis: Rohit Gupta, MD
3
ASN Kidney Week 2026 Recap: 8 Key Updates in Kidney Disease to Know
4
HCPLive Five at CHEST 2026
5

